objectives To evaluate the diagnostic utility of enrichment culture and PCR for improved case detection rates of non-bacteraemic form of melioidosis in limited resource settings.
Introduction
Early and accurate diagnosis in adjunct with pathogenspecific antimicrobial therapy can significantly reduce the relapse and case fatality rates among patients with melioidosis [1] . In endemic regions where human infection occurs due to inhalation or inoculation of the bacteria from soil, melioidosis presents commonly as community-acquired pneumonia followed by soft tissue and/or visceral organ abscesses (commonly referred as 'localised melioidosis') [2] . Bacteraemic/septicaemic melioidosis is a fatal complication of the localised form of disease among patients with pre-existing comorbidities such as diabetes mellitus, thalassaemia and chronic kidney disease. Given this context, early detection of Burkholderia pseudomallei from relevant clinical specimens, when the disease is still localised (pulmonary, cutaneous and visceral abscesses) seems a logical approach to reduce the occurrence of bacteraemic form of the disease and the associated mortality.
Isolation of B. pseudomallei from body fluids of patients using microbiological culture is widely accepted as the gold standard for diagnosis of melioidosis [3] . Identification of B. pseudomallei is not usually a significant problem for laboratories in highly endemic regions like north-east Thailand and northern territory of Australia. However, the increase in travel to and from endemic areas will make it inevitable that laboratories, otherwise not familiar with the organism, would be confronted with diagnostic challenges and dilemmas relating to its identification. Burkholderia pseudomallei is increasingly gaining recognition as a common aetiological agent for community-acquired bacteremia, lower respiratory tract infections, skin, bone and soft tissue infections in developing tropical nations such as India, Sri Lanka, Bangladesh and the surrounding South-Asian countries. However, the exact prevalence of melioidosis in these nations' remain far from well -elucidated, and it is assumed that the disease remains underdiagnosed in many instances [4] . Such an underdiagnosis can be attributed to the protean clinical manifestations and lack of pathognomonic clinical signs and symptoms among the infected; lack of awareness and training among the clinicians and microbiologists and unavailability of rapid and reliable diagnostic tests for routine use.
With this background, this study was undertaken to evaluate the performance of conventional culture, enrichment culture and PCR for detection of B. pseudomallei from clinical specimens other than blood. As an additional outcome of the study, we used Bayesian latent class model to deduce the diagnostic accuracies of the aforementioned three techniques for non-bacteraemic form of melioidosis in endemic settings with limited resources.
Materials and methods

Study site
This study was undertaken during January 2014-December 2015 at a microbiology laboratory of a 2030 bed teaching hospital in South India. Study site reports nearly 20-25 cases of culture-confirmed melioidosis cases annually with peaks during monsoon months of June-November every year.
Study specimens
Clinical specimen (non-blood) received at the study site for routine microbiological culture from patients admitted to the teaching hospital with symptoms suggestive of community-acquired pneumonia, lower respiratory tract infections, superficial or internal abscesses, chronic skin ulcers and bone or joint infections were considered for inclusion in the study. Patients diagnosed with respiratory illness due to viral aetiology were not included in the study. Also, clinical specimens obtained from patients diagnosed with bacteraemic form of melioidosis (positive blood cultures for B. pseudomallei) were not included in the study.
Conventional and enrichment culture
Microbiological processing of the study specimens was strictly performed in biosafety cabinets with personnel protective equipment. Respiratory specimens, exudates and wound swabs were cultured conventionally on 5% sheep blood agar (SBA) and MacConkey agar (MA). These specimens were additionally cultured in CV-C50 broth also for enrichment followed by subculturing on MA after 48 hours [5] . All culture plates were examined for the growth of oxidase-positive colonies of Gramnegative bacilli characteristic of B. pseudomallei for up to five days after inoculation. Suspected colonies were identified using standard biochemical reactions showing positive oxidase reaction, arginine dihydrolysed and resistance to colistin and gentamicin but susceptible to amoxicillin clavulanic acid. Identification of the isolates was confirmed using further monoclonal antibody-latex agglutination (Mab-LA) test specific for B. pseudomallei obtained from Mahidol Oxford RU, Bangkok, Thailand. The Mab-LA test for B. pseudomallei was reported to have a specificity of nearly 98% previously [6] .
PCR
DNA extraction from clinical specimens was performed using QiaAMP DNA mini kit (QIAGEN, Hilden, Germany) and eluted in 150 ll volume as per the manufacturer's instructions. The extracted DNA was preserved at À70°C until further tested. Conventional-PCR targeting a Type III secretion system gene cluster (TTS1) was performed using oligonucleotide primers (Forward:5 0 -CTTCAAT CTGCTCTTTCCGTT-3 0 and Reverse: 5 0 -CAGGACG GTTTCGGACGAA-3 0 ), as reported previously [7] . Primers targeting the ORF2 of the TTS1 gene cluster was reported to exhibit high diagnostic sensitivity and specificity (100%) for B. pseudomallei [7, 8] . The PCR reaction mix consisted of a final reaction volume of 25 ll containing 5 ll of template DNA, 1 unit of Taq DNA polymerase, 19 PCR buffer, 200 lM each of dNTPs and 500 nM of each oligonucleotide primer. Amplification was performed with an initial denaturing step at 95°C for 30 s, 60°C for 30 s and 72°C for 30 s for 35 cycles; and a final extension step at 72°C for 2 min. Product (548 bp) was visualised by 2% agarose gel electrophoresis, stained with ethidium bromide and UV illumination. For each run of PCR, a known-biotyped isolate of B. pseudomallei as a positive control and molecular grade water as the negative control were used.
Statistical analysis
Data were analysed using SPSS v. 15.0 (IBM, Bangalore, India). Diagnostic sensitivities, specificities, positive and negative predictive values of conventional culture and PCR were estimated using 2 9 2 tables with enrichment culture as the reference gold standard method. Further, data were analysed using Bayesian latent class model considering all the three diagnostic modalities as imperfect and also: (i) each subject is independent and identically distributed; (ii) tests are independent of other tests; and (iii) all tests are detecting the parameter of interest, that is true disease. Bayesian latent class modelling was performed using the MICE tool (Modelling for Infectious disease Center, Mahidol-Oxford Research Unit), freely available online upon registration (http://mice.tropmedre s.ac/home.aspx.). Prevalence of melioidosis in the study population was deduced initially using conventional culture positivity rate alone, followed by the overall detection rate of B. pseudomallei using the Bayesian latent class model.
Results
A total of 525 clinical specimens obtained from patients suspected with melioidosis during the study period were included. Majority of the specimens were sputum (202, 38%) followed by wound swabs (102, 19.4%) and pus (99, 18.8%). Culture positivity rates for B. pseudomallei using conventional microbiological culture among patients suspected with pulmonary and localised forms of melioidosis were 1.5% and 5.9%, respectively. Microbiological culture findings of the study specimens are shown in Table 1 .
Overall, the detection rates of B. pseudomallei using conventional, enrichment culture and PCR were 3.8% (n = 20), 5.3% (n = 28) and 6% (n = 32), respectively. A detailed description of the clinical specimens and detection rates using each of the three diagnostic modalities is displayed in Table 2, whereas Table 3 (11) 11 (4.5) 0 Beta Hemolytic Streptococci (10) 5 (1.9) 5 (1.8) Enterobacter spp (8) 1 (0.3) 7 (2.5) Haemophilus influenzae (4) 4 (1.5) 0 Finally, an increase of 1.6% (1.08-4.32%) in the case detection rate of melioidosis was observed in the study population when tested using enrichment culture and/or PCR positivity (5.4%; 95% credible interval: 4.8-7.6%) vs. conventional culture alone (3.8%; 95% confidence interval: 2.6-5.4%).
Discussion
Isolation of B. pseudomallei by microbiological culture from clinical specimens is diagnostic for melioidosis. Serological detection of antibodies against B. pseudomallei using indirect hemagglutination assay (IHA) in disease-endemic settings has limited diagnostic utility [8, 9] . Antigen detection using immunofluorescence assay (IFA) and real-time PCR assays targeting pathogenic DNA were reported to have good diagnostic accuracies in research facilities or referral laboratories. However, the need for technical expertise and the costs involved in testing hinder their routine use in diagnostic microbiology laboratories with limited resources. Lack of pathogen-specific clinical features, and the fact that melioidosis mimics other tropical infections pose a challenge for clinical suspicion of the disease. As a consequence of this, selection of clinical specimens for additional testing becomes difficult for microbiologists particularly when resources are scarce. In the present study, we used a simple and feasible criteria for selection of study specimens for additional testing using enrichment culture and PCR as reported previously [10] . Also, we used the Bayesian latent class model to elucidate the diagnostic accuracies of conventional culture, enrichment culture and PCR for non-bacteraemic form of melioidosis.
An increment in the detection rates of B. pseudomallei from respiratory specimens when selective media were used along with conventional culture was previously reported in low prevalence settings [11] . Numerous formulations were proposed for selective enrichment of B. pseudomallei from both clinical and environmental specimens in the literature [12, 13] . In the present study, we used CV-C50 enrichment broth containing crystal violet and colistin as the selective agents. CV-C50 broth was reported to be useful medium for isolation of B. pseudomallei from environmental specimens [14] . However, the utility of this broth on clinical specimens was less evaluated. Of the 252 respiratory specimens included in our study, B. pseudomallei was detected among seven (2.7%) and four (1.5%) specimens using enrichment and conventional cultures, respectively. Similar increment in the culture positivity rates was also observed from pus and exudate specimens using enrichment culture (7.7%) vs. conventional culture (5.9%). Further, we faced the challenge of identifying B. pseudomallei on conventional culture media plates (SBA and MA), particularly in situations when there was an overgrowth of commensal flora and also when several colony morphotypes of B. pseudomallei, mimicking contaminants, were observed (http://www. melioidosisindia.com/photo-gallery). In their seminal work to deduce the true sensitivity of culture techniques for melioidosis, Direk et al. used the Bayesian latent class model and reported a sensitivity of 60.2% vs. serological diagnosis of melioidosis [3] . Sensitivity of conventional culture using gold standard model and Bayesian latent class modelling deduced in the present study was 71.4% and 70.3%, respectively vs. enrichment culture and PCR. Put together, these findings add strength to the possibility of underdiagnosis of melioidosis in settings where conventional culture remains the only diagnostic test of choice.
The diagnostic utility of PCR for melioidosis remains debatable. Of the 525 specimens tested in the present study, PCR positivity for B. pseudomallei was observed among 32 (6%) specimens. PCR could detect the entire culture positive specimens and further detected B. pseudomallei from four specimens (three sputum and one pus), which were negative by enrichment culture. Detection of B. pseudomallei DNA from clinical specimens qualitatively alone (even when culture is negative) can be diagnostic for melioidosis as these bacteria are not a part of the host commensal flora. Diagnostic sensitivity of PCR using gold standard and Bayesian latent class modelling in the present study was 100% and 99.3%, respectively. Nevertheless, diagnostic accuracies of PCR assays can vary based on the type of clinical specimens tested. It is known that the PCR can give false-negative results when tested on direct blood specimens due to bacterial load (<10 CFU/ ml), which is generally below the lower detection limits of any PCR assay. On the contrary, PCR can be an effective test for diagnosis of localised melioidosis, as observed in our study, using specimens such as sputum and pus which are known to have high loads of bacteria (10 2 -10 9 CFU/ ml). Time for positivity using conventional and enrichment cultures in our study was 2-5 days, whereas PCR can be performed and reported within 6-8 h.
Conclusions
We evaluated different culture methods and PCR for an accurate and rapid diagnosis of melioidosis to suit the needs of clinical microbiology laboratories in developing nations that require more rigorous case finding. Our findings underscore the possibility of underdiagnosis of melioidosis in settings where conventional culture of clinical specimens remains the diagnostic test of choice. In such instances, inclusion of enrichment culture and/or PCR according to availability and affordability would strengthen the ability of microbiology laboratories to detect B. pseudomallei from clinical specimens other than blood.
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